Related Experiment Video
Updated: Jun 20, 2026

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers
Published on: February 26, 2018
A permeability assay adapted for the assessment of very poorly permeable compounds in the bRo5 space
Paulina Page1, Dallas Bednarczyk1
1Pharmacokinetic Sciences, Novartis Institutes of BioMedical Science, Cambridge, MA, USA.
Abstract:
Poorly permeable compounds in the beyond rule of 5 (bRo5) space often demonstrate acceptor well concentrations below the lower limit of quantification or limited resolution between apparent permeability (Papp) values. To address the acceptor well concentration limitation and better resolve differences between poorly permeable molecules, a straightforward solution was proposed, extend the incubation time from 2-h to 24-h to enable acceptor well concentrations to achieve quantifiable values. MDCK cells with knock out of the endogenous canine Mdr1 gene (MDCK-KO) were seeded on 96-Tanswell plates and grown to confluence over three days at which point the 24-h assay was initiated. The longer incubation time enabled receiver compartment concentrations to exceed limits of quantification enabling Papp determination in a test set of approximately 30 molecules. The approximately 10-fold increase in incubation time enabled Papp value determination of up to an order of magnitude lower compared to a 2-h incubation. The assay demonstrates good reproducibility and resolution between poorly permeable compounds. In summary, a straightforward modification of a traditional Transwell permeability assay has produced an assay suitable for the measurement and resolution of very poorly permeable compounds.

